Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol Myers Squibb Just Got Some Great Regulatory News
Bristol Myers Squibb Just Got Some Great Regulatory News
Bristol Myers Squibb Just Got Some Great Regulatory News
Submitted by
admin
on November 2, 2021 - 10:45am
Source:
Motley Fool
News Tags:
Bristol Myers Squibb
Zeposia
Europe
ulcerative colitis
Headline:
Bristol Myers Squibb Just Got Some Great Regulatory News
snippet:
If approved in the EU, Zeposia would gain access to a large ulcerative colitis market.
An ulcerative colitis approval in the EU could net $400 million in annual revenue for Bristol Myers Squibb.
Bristol Myers Squibb's 3.4% yield is safe and poised to rise in the years ahead.
Do Not Allow Advertisers to Use My Personal information
